- Release Date: 07/10/21 08:27
- Summary: MAYNE PHARMA provides FDA update on generic NUVARING
- Price Sensitive: No
- Download Document 142.82KB
Ann: MAYNE PHARMA provides FDA update on generic NUVARING
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.26 |
Change
-0.020(0.47%) |
Mkt cap ! $362.4M | |||
| Open | High | Low | Value | Volume |
| $4.28 | $4.37 | $4.20 | $1.216M | 284.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12486 | $4.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.27 | 1060 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |